Auranofin
1 NDC across 1 manufacturer|0 Generic,1 Brand
Auranofin is used to treat psoriatic arthritis, rheumatoid arthritis and pemphigus, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 24, 1985. In 2024, Medicare Part D spent $922K on Auranofin across 635 claims for 88 beneficiaries.
Auranofin is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $24.85 to $24.85 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$24.85 – $24.85
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Sebela Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing AURANOFIN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
RIDAURA 3 MG CAPSULE | $24.8454 per EA | — |
Frequently Asked Questions
What is Auranofin used to treat?
Auranofin is used to treat psoriatic arthritis, rheumatoid arthritis and pemphigus, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Auranofin?
In 2024, Medicare Part D spent $922K on Auranofin across 635 claims for 88 beneficiaries.
How many Auranofin products are on the market?
The Auranofin drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Auranofin?
NADAC reference prices for Auranofin range from $24.8454 to $24.8454 per EA.
Which manufacturers make Auranofin?
1 manufacturer lists Auranofin in NADAC. Ranked by number of NDCs, the largest are Sebela Pharmaceuticals Inc. (1).